UPDATE : Monday, February 17, 2020
상단여백
New Parkinson’s drug Ongentys lands on Korea by Jeong Sae-im 2019-11-28 14:52
Kolon Life Science’s research head arrested for false Invossa data by Jeong Sae-im 2019-11-28 11:18
SK Chemicals wins FDA nod for patch-type Alzheimer’s drug by Jeong Sae-im 2019-11-27 18:24
Roche Diagnostics challenges IBM Watson with differentiated strategy in tailor-made treatment market by Jeong Sae-im 2019-11-21 15:48
Oncologists vow to fight cancer through precision medicine by Jeong Sae-im 2019-11-21 14:28
라인
Vivozon’s acquisition of Lumimicro may aim at backdoor listing by Jeong Sae-im 2019-11-20 14:44
PharmAbcine registers 1st patient for phase-2 trial on olinvacimab by Jeong Sae-im 2019-11-19 17:18
‘New law needed to curb rising chronic kidney disease’ by Jeong Sae-im 2019-11-19 11:45
‘Udenafil improved exercise in single ventricle heart disease’ by Jeong Sae-im 2019-11-18 14:48
Prosecutors raid drugmakers, distributors for suspected bid-rigging by Jeong Sae-im 2019-11-14 15:27
라인
How can Korean drugmakers enter Europe successfully? by Jeong Sae-im 2019-11-13 15:22
Samsung Bioepis expects ₩1 trillion biosimilar sales this year by Jeong Sae-im 2019-11-13 15:21
[News Focus] ‘FDA could allow resumption of Invossa trial’ by Jeong Sae-im 2019-11-12 15:48
Eunpyeong St. Mary’s Hospital adopts AI nursing documentation by Jeong Sae-im 2019-11-12 15:47
Genexine’s new immunotherapy shows stability even in high dose by Jeong Sae-im 2019-11-11 13:36
라인
‘Cancer patients suffered side effects after taking anthelmintic drug’ by Jeong Sae-im 2019-11-08 13:30
‘Lung cancer screening was effective in numerous studies’ by Jeong Sae-im 2019-11-07 14:06
Court rejects arrest warrant for 2 Kolon execs by Jeong Sae-im 2019-11-05 13:54
Yuhan, Dong-A, HanAll see Q3 earnings jump on licensing-out deals by Jeong Sae-im 2019-11-04 15:52
Kolon allegedly knew Inovossa mislabeling before applying for approval by Jeong Sae-im 2019-11-01 15:07
여백
여백
여백
Back to Top